Acute kidney injury
RecruitingA study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis
- Disease:Acute kidney injury
- Substances:–
France- Participants:18–64 years · 65+ years
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to France9 clinical trials in Brive La Gaillarde, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on sustained immunosuppression in ICU patients, exploring interferon gamma therapy to prevent secondary infections. The trials aim to enhance immune system function in critically ill patients.
Studies evaluate standardized treatment protocols to improve patient outcomes in intensive care settings.
Groundbreaking studies in breast cancer treatment optimization and chronic myeloid leukemia management, focusing on personalized therapeutic approaches.
Research aims to refine treatment durations while maintaining optimal patient outcomes.
Advanced research on treating catheter-related bloodstream infections, particularly focusing on Staphylococcus aureus infections with innovative antibiotic approaches.
Studies compare traditional and novel antibiotic therapies for improved infection control.
Critical research addressing cardiac arrest and septic cardiomyopathy, evaluating specialized treatments for improved patient survival.
Trials focus on emergency interventions and preventive treatments in critical cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.